Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers

Daniel Umbricht1, Rene Koller, Franz X Vollenweider

  • 1Psychiatric University Hospital Zurich, Department of Psychiatric Research, Zurich, Switzerland.

Biological Psychiatry
|March 21, 2002
PubMed
Abstract

Insights

Smaller mismatch negativity (MMN) suggests NMDA receptor (NMDAR) systems are more vulnerable to ketamine disruption. This finding indicates MMN reflects NMDAR neurotransmission function in healthy individuals.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Auditory Event-Related Potentials

Background:

  • Mismatch negativity (MMN), a preattentive auditory event-related potential (ERP), is linked to N-methyl-D-aspartate receptor (NMDAR) function.
  • Previous research suggests a connection between MMN and NMDAR activity.

Purpose of the Study:

  • To investigate if MMN amplitude reflects the functional state of the NMDAR system in healthy volunteers.
  • To examine the relationship between pre-drug MMN and responses to ketamine and psilocybin.

Main Methods:

  • MMN was recorded in response to frequency and duration deviants before administering ketamine or psilocybin.
  • Behavioral and subjective effects were assessed using the Brief Psychiatric Rating Scale and OAV Scale.
  • Correlations between MMN, N1, P2 amplitudes and drug effects were analyzed.

Main Results:

  • Reduced MMN amplitude correlated with stronger ketamine effects.
  • No significant correlations were found between MMN and psilocybin effects.
  • N1 and P2 amplitudes did not show significant correlations with drug effects.

Conclusions:

  • Lower MMN amplitude indicates greater NMDAR system vulnerability to ketamine.
  • MMN generation serves as an indicator of NMDAR-mediated neurotransmission function, even in individuals without psychopathology.